TRACON Pharmaceuticals, Inc. (NASDAQ:TCON – Get Free Report) was the recipient of a significant decrease in short interest in August. As of August 15th, there was short interest totalling 237,900 shares, a decrease of 31.8% from the July 31st total of 348,700 shares. Based on an average trading volume of 449,900 shares, the short-interest ratio […]